---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-016850"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2025-10-03T23:59:59+00:00"
generated_at: "2026-05-17T04:43:58.385999+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# INVO Fertility settles litigation with Dr. Pritts for $6.01M; issues preferred shares

## Summary
- Settlement requires Wood Violet to pay Dr. Pritts $6,010,000 in installments through Dec 2026, with $1M already paid.
- Remaining payments: $755k due Sep 30, 2025; $755k Dec 31, 2025; $1M Mar 31, 2026; $2M Jun 30, 2026; $500k Dec 31, 2026.
- If INVO raises >$2M in any 6-month period, 25% of excess funding accelerates settlement payments.
- Institutional investor exercises Additional Investment Right, acquires 400 shares of Series C-2 Preferred for $400k cash, conversion price adjusted to $0.7141.
- Settlement terminates all transaction documents, purchase price adjustments, and restrictive covenants; Dr. Pritts released from non-compete.

## SEC filing metadata
- accession: 0001493152-25-016850
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2025-10-03T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/0001493152-25-016850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-016850
- JSON: https://secwatch.observer/filing/0001493152-25-016850.json
- Plain text: https://secwatch.observer/filing/0001493152-25-016850.txt

## Key facts
- Equity Issuances
  INVO Fertility, Inc. issued 400 shares of C-2 Preferred of preferred stock to an institutional investor and existing holder for $400,000.
  - Security: preferred stock
  - Shares: 400 shares of C-2 Preferred
  - Purchaser: an institutional investor and existing holder
  - Consideration: $400,000
  source text: became a party pursuant to a joinder agreement (the “ Joinder Agreement ”) on October 11, 2024), to acquire 400 shares of C-2 Preferred, with an aggregate stated value of $400,000, for $400,000 in cash. As a result of the exercise, the conversion price on the C-2 Preferred adjusted to $0.7141 per share. The C-2 Preferred issued pursuant to this exercise were
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315225016850/0001493152-25-016850-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.